prostate

Momentm Health is an exciting new independent healthcare provider of expert diagnostics and therapeutic procedures located in the heart of Cambridgeshire. Founded by a team of experienced clinicians from Cambridge hospitals, Momentm Health brings together world-leading orthopaedic surgeons, rheumatologists, sports medicine specialists and radiologists with a mission to provide swift, high-quality diagnostic care. Founded in […]

At this year’s ESTRO Congress in Vienna, Austria, Micropos Medical hosted a seminar on augmented stereotactic body radiation therapy (SBRT), a concept encompassing technologies for motion tracking and enhanced methods for accuracy in radiotherapy for prostate cancer, with a focus on treatment outcomes and quality of life. The seminar brought together experts in the field […]

Edinburgh Cancer Centre has recently begun treating prostate cancer patients within the framework of the Precision Study. Patients receive only three radiation doses, with the Raypilot System used as a complement to ensure accurate motion control during treatment, thereby minimising potential side effects. The aim is to demonstrate that three sessions work as well as […]

Men with localised prostate cancer are often faced with the choice of treating the disease with surgery or radiation. Both methods are equally effective in curing the cancer, but the extent of potential side effects varies. A long-term study shows that sexual function deteriorates significantly more, and for more patients, following surgery. Urinary incontinence issues […]

Results have been published from a British long-term follow-up study of 874 prostate cancer patients who received either conventional radiation therapy in 20 or 39 sessions or stereotactic body radiotherapy (SBRT) involving higher radiation doses in five sessions. The results showed that treatment outcomes are equally effective for patients treated five times compared to those […]

Leeds Teaching Hospitals NHS Trust is piloting an AI tool designed to improve prostate cancer diagnosis. In collaboration with Lucida Medical, the trust is testing the effectiveness of the Prostate Intelligence (Pi) tool, an advanced AI and machine learning software system, in detecting prostate cancer lesions from MRI scans. Patients with prostate cancer face a complex diagnostic […]

Installation of an Arietta 850 DeepInsight diagnostic ultrasound system at Bradford Royal Infirmary has enhanced capabilities in both the transperineal (TP) prostate biopsy room and theatre practice, according to Fujifilm Healthcare, which manufactures the system. The trust chose the system to support multiple and specialised uses. Initially purchased for TP biopsies, the Arietta 850 DeepInsight […]

Prostate cancer is the second most prevalent cancer in men globally. Recent advancements in MRI technology have substantially improved the ability to detect and characterise prostate tumours. The Prostate Imaging-Reporting and Data System version 2.1 (PI-RADS v2.1) has been critical in improving the detection, localisation, characterisation, and risk stratification of lesions in untreated prostate glands, […]